StockData
Kiniksa Pharmaceuticals International, plc logo

Kiniksa Pharmaceuticals International, plc (KNSA) stock

KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30469% above fair value
$95.05−0.06 (-0.06%)

Close on Nov 18, 2026Market cap $14.94BP/E 73.1Yield –

Kiniksa Pharmaceuticals International total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Kiniksa Pharmaceuticals International

Kiniksa Pharmaceuticals International has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Kiniksa Pharmaceuticals International figures

See a number that looks wrong?